Clinical Trial Update: Platelet Drug Trial in Coronary Disease Progression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a platelet-targeted therapy for progression of coronary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Platelet drug

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED